XML 111 R97.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Merger Agreement and Asset Sale (Details) $ in Thousands | Dec. 17, 2024 USD ($)
--- | ---
Merger Agreement and Asset Sale [Line Items] |
Termination Fee | $ 2,250
Reimbursed expenses | 750
Vifor Fresenius Medical Care Renal Pharma Ltd Agreement [Member] |
Merger Agreement and Asset Sale [Line Items] |
Asset Disposition, purchase price | 900
Additional compensation for Asset Disposition | $ 3,000
Cara Therapeutics, Inc | Pre-Merger equity holders of company |
Merger Agreement and Asset Sale [Line Items] |
Subsidiary, Ownership percentage | 15.25%
Cara Therapeutics, Inc | Pre-Merger Equity Holders of Tvardi |
Merger Agreement and Asset Sale [Line Items] |
Subsidiary, Ownership percentage | 72.21%
Cara Therapeutics, Inc | Holders of Tvardi Convertible Notes |
Merger Agreement and Asset Sale [Line Items] |
Subsidiary, Ownership percentage | 12.54%

X
- Definition The amount agreed to pay to the third party for estimated incremental future expenses. + References No definition available. + Details
Name: | cara_DispositionOfAssetsAmountPayableForEstimatedIncrementalFutureExpenses
Namespace Prefix: | cara_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of purchase price for asset disposition. + References No definition available. + Details
Name: | cara_DispositionOfAssetsPurchasePrice
Namespace Prefix: | cara_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | cara_MergerAgreementAndAssetSaleLineItems
Namespace Prefix: | cara_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of maximum reimbursement of certain expenses if merger does not close under termination agreement. + References No definition available. + Details
Name: | cara_TerminationAgreementIfMergerDoesNotCloseMaximumAmountToBeReimbursed
Namespace Prefix: | cara_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of termination fee to be incurred if merger does not close under termination agreement. + References No definition available. + Details
Name: | cara_TerminationAgreementIfMergerDoesNotCloseTerminationFeeToBeIncurred
Namespace Prefix: | cara_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=cara_ViforFreseniusMedicalCareRenalPharmaLtdAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=cara_CaraTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cara_PreMergerEquityHoldersOfCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cara_PreMergerEquityHoldersOfTvardiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cara_HoldersOfTvardiConvertibleNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |